Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Tag Archives: USPTO
Are Abstract Ideas Not Actually Abstract?
The following post is from Jim Hallenbeck of Schwegman, Lundberg & Woessner. The disposition of Bilski rested on a holding that Bilski’s claims were directed to an abstract idea – hedging. (Decision at end of post.) The root case for … Continue reading
Posted in Patent Eligible Subject Matter
Tagged Bilski, intellectual property, ip, jim Hallenbeck, Patent Law, USPTO
2 Comments
Bilski Claims Fail As Attempt To Claim “Abstract Idea” – Future Of Business Method Patents Cloudy
Today, the Supreme Court affirmed the rejection of Bilski’s claims. (Attached at end of posting.) The 16 page Opinion of the Court was authored by Justice Kennedy, joined in full by Justices Thomas, Roberts, and Alito. The opinion held that … Continue reading
Patent Office Says, “Have It Your Way!” For A Price.
The PTO has proposed a “Three-Track Examination” option for applicants which gives them the opportunity to jump to the head of the examination line (goal: 12 mo. pendency with first office action within two months) or to put the application on … Continue reading
Posted in USPTO Practice and Policy
Tagged biotechnology law, Patent Law, patents, USPTO, Warren Woessner
Leave a comment
Director Kappos Comments on Ariad v. Lilly
USPTO David Kappos recently posted a comment on the Fed. Cir. decision in Ariad v. Lilly in which he noted that the Fed. Cir. held that broad functional claims (presumably mechanism-of-action claims) must be supported by sufficient species (read “working examples”). While … Continue reading
Posted in Written Description Requirements (WDR)
Tagged Ariad v. Lilly, David Kappos, Patent Law, patents, USPTO, Warren Woessner
Leave a comment